[Saxagliptin/metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018002943
German
Original Title:
Saxagliptin/Metformin (neues Anwendungsgebiet)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a13-12.html
Year Published:
2013
URL for published report:
https://www.iqwig.de/download/A13-12_Saxagliptin-Metformin%20%28neues%20Anwendungsgebiet%29_Nutzenbewertung%20%C2%A7%2035a%20SGB%20V.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Diabetes Mellitus, Type 2
- Metformin
- Drug Therapy, Combination
- Hypoglycemic Agents
- Dipeptidyl-Peptidase IV Inhibitors
- Incretins
Keywords
- Saxagliptin
- Metformin
- Diabetes Mellitus - Type 2
- Benefit Assessment
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.